Loading asset research
Q2 2026 earnings · Sep 28
Benitec Biopharma Inc. Common Stock
BNTCNasdaq · USD · StocksQuote as of · Exchange session not verified$12.19
-0.25%
Today
BNTC
Loading 1D prices…
Market cap
$418.8M
Volume
88.6K
52w high
$16.7652w low
$9.85Company profile
Benitec Biopharma Inc. Common Stock
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Hayward, CA, United States
Employees
19
Fiscal year end
0630
CIK
1808898
Session & valuation
Open$12.38
Previous close$12.22
Day high$12.51
Day low$12.12
30-day avg. volume156.6K
Outstanding shares34.4M
Diluted EPS-$0.72
Latest annual period
P/E (trailing)-16.93
P/E (forward)-1.29
Price / book2.28
Beta0.27
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ARCTArcturus Therapeutics Holdings Inc. Common Stock | $418.7M | $82M | -80.19% | -$2.40 | +5.33% | Buy |
| AVIRAtea Pharmaceuticals Inc. Common Stock | $425.9M | $0.00 | — | -$1.94 | +2.51% | Buy |
| LRMRLarimar Therapeutics Inc. Common Stock | $407.2M | $0.00 | — | -$2.27 | +2.34% | Buy |
| RZLTRezolute Inc. Common Stock (NV) | $406.4M | $0.00 | — | -$0.55 | +0.96% | Buy |
| BBOTBridgeBio Oncology Therapeutics Inc. Common Stock | $396.9M | $0.00 | — | -$4.30 | -10.87% | Buy |